Perfil de la empresa · Healthcare

Johnson & Johnson

JNJ · EE. UU.
Bolsa
EE. UU.
País / Región
USA
Fecha de salida a bolsa
24 de septiembre de 1944
Empleados
138.200
Sitio web
www.jnj.com
Precio actual
$228.39
En vivo · 18 de junio de 2026
Puntuación de crecimiento Baillie
48/100
Floja
Valor intrínseco · Rango en tres niveles Precio actual $228.39 En vivo · Dentro del rango de valor intrínseco optimista · con muchas expectativas ya descontadas

Rango de valoración compuesto · conservador $120–$150 / razonable $150–$190 / optimista $190–$230. A $228.39, Dentro del rango de valor intrínseco optimista · con muchas expectativas ya descontadas.

Al publicar $234.34 (25 de mayo de 2026)

Aún no hay análisis sobre este valor en tu idioma.

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Capitalización563,77 mil MUS$
Ingresos (TTM)96,36 mil MUS$
EBITDA34,33 mil MUS$
Margen neto21,83 %
ROE26,42 %
PER (TTM)27,14
PER previsto20,24
PEG3,04
BPA8,63 US$
Rentabilidad por dividendo2,21 %
Rango de 52 semanas145,39 US$ – 250,24 US$
Precio objetivo de analistas252,87 US$
Recomendación de analistas3.8 / 5

Datos de EODHD, mostrados en la moneda de reporte; solo a título informativo, no constituye asesoramiento de inversión.

Historia

PróximamenteEsta sección se está completando; vuelve pronto.

Posición en el sector

PróximamenteEsta sección se está completando; vuelve pronto.